AARDVARK THERAPEUTICS INC (AARD:NASDAQ)
$5.44 -0.21 (-3.7168%)
Analysed AARDVARK THERAPEUTICS INC (AARD:NASDAQ) News Sources
Discover 3 Promising Penny Stocks With Market Caps Over $100M
17-04-2026
yahoo.com
Why Aardvark Therapeutics (AARD) Paused Late-Stage ARD-101 Trials After Cardiac Findings
29-03-2026
yahoo.com
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
23-03-2026
yahoo.com
A Look At Aardvark Therapeutics (AARD) Valuation After The Voluntary Pause Of Its Phase 3 HERO Trial
05-03-2026
yahoo.com
Aardvark Therapeutics (AARD) Is Down 61.4% After Pausing Phase 3 HERO Trial Over Cardiac Safety Questions
04-03-2026
yahoo.com
Why Aardvark Therapeutics Just Lost More Than Half Its Value
02-03-2026
yahoo.com
Sector Update: Health Care Stocks Retreat Late Afternoon
02-03-2026
yahoo.com
Safety concerns spur Aardvark to halt key Prader-Willi drug trial
02-03-2026
biopharmadive.com
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
27-02-2026
yahoo.com
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13-02-2026
yahoo.com
What is the current price of AARDVARK THERAPEUTICS INC (AARD:NASDAQ)?
The current price of AARDVARK THERAPEUTICS INC (AARD:NASDAQ) is $5.44.
AARDVARK THERAPEUTICS INC (AARD:NASDAQ) absolute price change since previous trading day?
The absolute price change of AARDVARK THERAPEUTICS INC (AARD:NASDAQ) since the previous trading day is $-0.21.
AARDVARK THERAPEUTICS INC (AARD:NASDAQ) percentage price change since previous trading day?
The percentage price change of AARDVARK THERAPEUTICS INC (AARD:NASDAQ) since the previous trading day is -3.7168%.
What is the most recent average sentiment score for AARDVARK THERAPEUTICS INC (AARD:NASDAQ)?
The most recent average sentiment score for AARDVARK THERAPEUTICS INC (AARD:NASDAQ) is 58 out of 100.
What is the most recent average sentiment for AARDVARK THERAPEUTICS INC (AARD:NASDAQ)?
The most recent sentiment for AARDVARK THERAPEUTICS INC (AARD:NASDAQ) is .
SEC-8K** Filing Available For AARDVARK THERAPEUTICS INC (AARD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.